Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Congrats to all on this one following through, happy for ya.
Mbay doesn't want your shares only your money
www.pumpsanddumps.com/2013/08/a-closer-look-at-awesome-penny-stocks.html
I bet everyone thought I was in on this pump LMAO Thats how you go fishing son
Not for banks or the rich
They want it to go up so they can keep shorting leaving potheads with the bag pun intended
Franky baby,
https://www.youtube.com/watch?v=GdPfFfI1dn4
Peeps holding strong so I say
Dear shorty here's a short story
You stepped on mgon and your legs gone
run 4 cover like red dawn
or get nailed like press-on
Still holding all mine MGON for the win
MGON has shorty droppin the F bomb
Just curious here, why does it say 2013-2014 on the pdf
School is in session. Don't short pot stocks.
Looking good, when the alarm wakes this up tell the clouds to make room or get swiss cheesed up.
I saw a 100 share pop up at that price around 8:30 or so.
I didn't private message you, but can I get in a little bit lower please.
SpectraScience Announces United Kingdom NHS Technology Alert
Marketwired
March 23, 2015: 09:15 AM ET
SpectraScience, Inc. (OTCQB: SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that a Technology Alert has been issued by the National Institute of Health Research (NIHR) which serves as the liaison between industry and the clinicians of the National Health Service (NHS) and facilitates clinical evaluations of new products and technologies of interest to the NHS. Technology Alerts are issued to inform NHS hospitals when newly supported technologies are commercially available.
The report can be downloaded in its entirety by going to the following link: http://www.hsc.nihr.ac.uk/topics/wavstat4-optical-biopsy-system-for-colorectal-canc/.
The report is based on the evaluation of the WavSTAT®4 Optical Biopsy System at St. James University Hospital in Leeds, England, as part of a European trial.
The WavStat trial in the UK was conducted in collaboration with the Colorectal Therapies Healthcare Technology Co-operative (HTC) based at St. James. Dr. Venkat Subramanian is the principal investigator for the UK trial.
The NHS was recently voted as the world's best healthcare system based on quality access and efficiency. Providing NHS clinical validation of WavSTAT4 has enabled SpectraScience to enter into the National Institute for Health and Clinical Excellence (NICE) MedTech evaluation program.
"NICE offers guidance on use of Medical technology across the NHS," said Michael Oliver, SpectraScience's President and CEO. "With the successful implementation of the clinical evaluation in the UK, we can quickly establish both the clinical and economic value for the NHS. This is in line with our goal to provide products and technologies that improve patient outcomes while reducing cost."
Mr. Oliver added, "Our WavSTAT4 Optical Biopsy System plays an important role in providing a fast, safe, accurate and cost-effective way to differentiate benign and cancerous lesions in the colon with a 96% negative predictive value. We look forward to implementations in multiple UK sites soon."
About SpectraScience, Inc.:
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
For more information:
Visit our web site www.spectrascience.com
Forward-Looking Statement for SpectraScience, Inc.
This news release contains forward-looking statements that involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.
Top of page
No revenues, only 75% conversion rates to keep the doors revolving with dilution.
What's the current market cap compared to that 4 mill
4 million dollar termination fee, very unlikely
www.benzinga.com/news/15/03/5349213/cig-wireless-termination-fee-under-merger-pact-is-4-0m-according-to-8-k-filing
Sorry, 8k says this part first followed by my first post. Upon the closing of the Merger, the outstanding Capital Stock (as defined below) of the Company will either be converted into the right to receive a pro rata portion of the Merger Consideration, or cancelled for no consideration, as follows:
Sorry, 8k says this part first followed by my first post. Upon the closing of the Merger, the outstanding Capital Stock (as defined below) of the Company will either be converted into the right to receive a pro rata portion of the Merger Consideration, or cancelled for no consideration, as follows:
each outstanding share of common stock, par value $0.00001 per share, of the Company (the “Common Stock” and, collectively with the Series A Preferred Stock and Series B Preferred Stock, the “Capital Stock”) will be canceled for no consideration.
Because the aggregate liquidation preferences of the Series A Preferred Stock under the Series A Certificate of Designation, which is currently calculated at $144.9 million, is estimated to be approximately $64.3 million greater than the aggregate Merger Consideration, the Merger Agreement provides that no consideration will be payable in respect of the Series B Preferred Stock (including accrued but unpaid dividends thereon) or the Common Stock.
Indeed, what do they have other than a website with an mj leaf?
I am not saying a bounce isn't possible, but if that happens and it will be shorted into trips. GLTU
Not at all. In fact my favorite plays are going long on turnaround stories. I look into every stock with the intention of doing just that. This is headed lower. Eye spy a BEAR that wants to short this;)
Did you seriously just compare Tweed to MGON? Please elaborate. Tweed is a real company with operations and MGON literally has N>O>T>H>I>N>G>!!!
A real company paying their bills, gotta love that. It would be nice if they can get a piece of that pie. Could be a summer sizzler.
Great post. 100% agreed
Please delete previous post. TIA
LMAO at the reply you got. Go back to the beginning of this pump and you will see all of the false info Cheeky was posting, reliable guy that cheeky.
Is that the rinse/repeat cycle you speak of this monster, 10 years?
Call his bluff, the phone # is on the ask
You know you don't really want those shares, just trying to induce buying.... any biters
You mean the FACTS
Does everybody have their bags packed for the trips
www.hotstocked.com/article/89580/has-hds-international-corp-otcmkts-hdsi-hit.html
Look at financials, dilution sure to follow
Until the bids build then...DUMP
I thought this flight was cancelled dilution downpour, nothing proprietary, 100 downloads for app, and Apple is going to take your pie
Why didn't they just make it 100 milly, just as believable
Convenient time for the pump eh, don't buy the bag, any turd will go up if you throw enough money at it